首页|期刊导航|中华医学杂志（英文版）|Current status and future perspectives of bispecific antibodies in the treatment of lung cancer

Current status and future perspectives of bispecific antibodies in the treatment of lung cancer

Wanying Wang Tianyu Qiu Fei Li Shengxiang Ren

中华医学杂志（英文版）2023，Vol.136Issue(4)：379-393,15.

中华医学杂志（英文版）2023，Vol.136Issue(4)：379-393,15.DOI:10.1097/CM9.0000000000002460

Current status and future perspectives of bispecific antibodies in the treatment of lung cancer

Wanying Wang ¹Tianyu Qiu ¹Fei Li ²Shengxiang Ren¹

作者信息

1. Department of Medical Oncology,Shanghai Pulmonary Hospital and Institute of Thoracic Cancer,School of Medicine,Tongji University,Shanghai 200433,China
2. Department of Pathology,School of Basic Medical Sciences,Fudan University,Shanghai 200032,China
折叠

摘要

关键词

Bispecific antibodies/Lung cancer/Immunotherapy/Targeted therapy

Key words

Bispecific antibodies/Lung cancer/Immunotherapy/Targeted therapy

引用本文复制引用

Wanying Wang,Tianyu Qiu,Fei Li,Shengxiang Ren..Current status and future perspectives of bispecific antibodies in the treatment of lung cancer[J].中华医学杂志（英文版）,2023,136(4):379-393,15.

基金项目

This work was sponsored by grants from the National Natural Science Foundation of China(Nos.82172869 and 81972167),the Program of Shanghai Academic Research Leader(No.21XD1423200),and the program of Shanghai Shenkang Hospital Development Center(No.SHDC12019133). （Nos.82172869 and 81972167）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航